The aim of this study is to compare the efficacy of a protocol using FSH alone with that of a protocol using FSH plus a GnRH antagonist for controlled ovarian hyperstimulation in cycles of elective freezing in the context of a donor/recipient programme.
The hypothesis to be tested is that an ovarian stimulation protocol that includes FSH alone without any LH surge prevention regimens is not inferior to a protocol including FSH plus a GnRH antagonist in terms of clinical outcome in a donor/recipient model. The formal sample size is calculated as follows: If there is a true difference in favour of the experimental treatment of 5% (20% vs 15%), then 160 patients (80 per group in case of 1:1 enrolment) are required to be 80% sure that the upper limit of a one-sided 95% confidence interval (or equivalently a 90% two-sided confidence interval) will exclude a difference in favour of the standard/control group of more than 10%. In the context of the present pilot study (as a first stage), the investigators intend to study 50 patients (25 per group in case of 1:1 enrolment). At a second stage the above mentioned sample size will be used.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
The GnRH antagonist in the control group (standard therapy) is administered from day 6 of FSH treatment at the dose of 0.25 mg per day until the triggering day and is injected each time immediately after the injection of FSH.
Rate of LH secretory peaks
A secretory peak of LH is defined as the increase at levels ≥10 IU/l.
Time frame: 3 weeks after start of ovarian stimulation.
Rate of concentration of progesterone >1 ng/ml
Concentration of progesterone elevation \>1 ng/ml
Time frame: At any time within 3 weeks after start of ovarian stimulation.
Rate of ongoing clinical pregnancy
Clinical pregnancy (fetal heart beat) at ultrasound
Time frame: 12 weeks after last menstrual period
Rate of miscarriage
Miscarriage / Loss of the embryo
Time frame: Within 20 weeks after last menstrual period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.